Topigen/Novagali Ocular, Respiratory Therapies Under Development
This article was originally published in The Pink Sheet Daily
Executive Summary
Cross-licensing deal gives Novagali access to Topigen’s RNA-targeting platform for eye diseases, and Topigen access to Novagali’s Novasorb technology for respiratory conditions.